Home/Filings/4/0001127602-24-022299
4//SEC Filing

Leong Justin 4

Accession 0001127602-24-022299

CIK 0000943819other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 10:16 AM ET

Size

6.6 KB

Accession

0001127602-24-022299

Insider Transaction Report

Form 4
Period: 2024-08-15
Leong Justin
Chief Product Officer
Transactions
  • Award

    ReMed Common Stock

    2024-08-15+8,25927,000 total
  • Award

    ReMed Common Stock

    2024-08-15+87827,878 total
Footnotes (2)
  • [F1]Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest1/3each year on the anniversary of the grant.
  • [F2]Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthe grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001825782

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 10:16 AM ET
Size
6.6 KB